NL-OMON44558已完成不适用
Dihydropyrimidine dehydrogenase (DPD) deficiency and haematological abnormalities - DPD deficiency
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 12 至 99（—）
入选标准
- •- genetically and/or biochemically confirmed DPD deficiency
- •- written permission to participate to the study by the participant and/or the parents/caregivers in case of children or incompetent adults
排除标准
- 未提供
研究者
相似试验
招募中
不适用
Pre-treatment dihydropyrimidine dehydrogenase (DPYD) genotyping in patients receiving fluoropyrimidine (5-Fluorouracil or Capecitabine) chemotherapy: A clinical implementation study of the effect of individualised dosing on treatment related toxicitycancerCancer - Other cancer typesACTRN12621001117808Queensland Health - Metro North Health280
已完成
不适用
Determination of dihydropyrimidine dehydrogenase and thymidylate synthase activity in human peripheral blood mononuclear cells in healthy volunteers.DPD and TS enzyme activity1003754610027655NL-OMON36760Antoni van Leeuwenhoek Ziekenhuis40
招募中
不适用
A combination of pre-screening for DPD deficiency by genotyping/phenotyping methods and pharmacokinetics-guided dosing of 5-FU for precision treatment to prevent severe toxicity in gastrointestinal cancer patients.NL-OMON52496Isala Klinieken75
招募中
不适用
A combination of pre-screening for DPD deficiency by genotyping/phenotyping methods and pharmacokinetics-guided dosing of 5-FU for precision treatment to prevent severe toxicity in gastrointestinal cancer patientsNL-OMON29105Isala65
已完成
4 期
Results of Glucose-6-phosphate Dehydrogenase Deficiency Screening Relate with Cost of Phototherapy in Neonatal Hyperbilirubinemia; A Randomized Controlled TrialGlucose-6-phosphate dehydrogenase deficiency (G6PD deficiency) is one of risk factors that should decrease the phototherapy threshold to be lower than G6PD-normal neonates.hyperbilirubinemia, phototherapy, G6PD deficiency, neonate, screeningTCTR20220705006/A241